Westfield Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-288,329
| Closed | -$40.1M | – | 280 |
|
|
2018
Q3 | $40.1M | Buy |
288,329
+51,744
| +22% | +$7.19M | 0.28% | 119 |
|
|
2018
Q2 | $29.4M | Sell |
236,585
-2,495
| -1% | -$310K | 0.22% | 150 |
|
|
2018
Q1 | $26.6M | Buy |
+239,080
| New | +$26.6M | 0.21% | 156 |
|
|
2017
Q4 | – | Sell |
-453,167
| Closed | -$63.6M | – | 274 |
|
|
2017
Q3 | $63.6M | Buy |
453,167
+121,897
| +37% | +$17.1M | 0.49% | 73 |
|
|
2017
Q2 | $40.3M | Sell |
331,270
-27,942
| -8% | -$3.4M | 0.34% | 105 |
|
|
2017
Q1 | $43.6M | Buy |
+359,212
| New | +$43.6M | 0.37% | 94 |
|